SYNTROVET INCORPORATED – Trademark Portfolio

Entity Type: 03

SYNTROVET INCORPORATED holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 19 (Building Materials) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PRV/MARKER GOLD. The owner is based in Summit, NJ.

556 Morris Avenue

Summit, NJ 07901

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SYNTROVET INCORPORATED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

19
Building Materials (1 filing)

Building materials (non-metallic); non-metallic rigid pipes for building

Frequently Asked Questions

How many trademarks does SYNTROVET INCORPORATED have?

SYNTROVET INCORPORATED has 9 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 7 cancelled.

What trademark classes does SYNTROVET INCORPORATED file in?

SYNTROVET INCORPORATED files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 19 (Building Materials). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SYNTROVET INCORPORATED's most well-known trademarks?

SYNTROVET INCORPORATED's registered trademark portfolio includes well-known marks such as PRV/MARKER GOLD. These are among 1 currently registered trademark in the portfolio.

What is SYNTROVET INCORPORATED's trademark registration success rate?

SYNTROVET INCORPORATED has a 11% trademark registration rate, with 1 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.